Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Nuvectis Pharma Inc (NVCT)

Nuvectis Pharma Inc (NVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Early-Onset Cancer Trends Spark Interest in Promising Oncology Pipelines BayStreet.ca - Wed Dec 18, 8:38AM CST

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group News Commentary – The American Cancer Society has unveiled its Advances in Oncology – 2024 Research Highlights report,...

ONCY : 0.8310 (-6.36%)
PSNL : 5.75 (+9.32%)
ALXO : 1.6200 (+9.46%)
ONC.TO : 1.19 (-9.16%)
NVCT : 4.52 (-3.62%)
TEM : 35.54 (+7.60%)
Insider Purchase: 10% owner at $NVCT (NVCT) Buys 17,000 Shares Quiver Quantitative, Inc. - Mon Dec 16, 5:24PM CST

Marlio Charles Mosseri, a 10% owner of $NVCT ($NVCT), bought 17,000 shares of the company on 12-13-2024. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased...

NVCT : 4.52 (-3.62%)
Nuvectis Pharma to Present at the 2024 Ladenburg Virtual Oncology Innovators & Investors Symposium GlobeNewswire - Tue Dec 10, 7:00AM CST

NVCT : 4.52 (-3.62%)
Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer GlobeNewswire - Thu Nov 14, 6:00AM CST

NVCT : 4.52 (-3.62%)
Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights GlobeNewswire - Tue Nov 5, 6:00AM CST

NVCT : 4.52 (-3.62%)
Nuvectis Pharma Announces Upcoming Presentations for NXP900 at the 2024 AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics GlobeNewswire - Wed Oct 23, 7:00AM CDT

NVCT : 4.52 (-3.62%)
Nuvectis Pharma to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference GlobeNewswire - Mon Oct 7, 7:00AM CDT

NVCT : 4.52 (-3.62%)
People and teaching - Two Colleagues Talking About Markets
Bump up Your Long Term Portfolio Performance With Low Beta Stocks Barchart - Wed May 17, 2023

In this article, discover how low beta stocks can shimmer in your portfolio!

MSFT : 436.60 (-0.10%)
NERV : 2.16 (+0.93%)
STIX : 0.3000 (-19.14%)
SERA : 8.78 (+8.00%)
TCRX : 2.97 (+1.37%)
NVCT : 4.52 (-3.62%)
Nuvectis Pharma, Inc. Reports Second Quarter 2022 Financial Results and Business Highlights Globe Newswire - Fri Aug 5, 2022

NXP800 Phase 1a Dose-Escalation Study Progressing as Planned, Commencement of Phase 1b Expansion Study Expected in Q1 2023NXP800 IND Cleared by the U.S....

NVCT : 4.52 (-3.62%)
Nuvectis Pharma Announces Closing of Approximately $15.9 Million Private Placement Globe Newswire - Mon Aug 1, 2022

Fort Lee, NJ, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (Nasdaq: NVCT) (“Nuvectis” or the “Company”), a biopharmaceutical company focused...

NVCT : 4.52 (-3.62%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot